Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fla. Legalizes Medical Marijuana Today - Update from FloridaMarijuanaInfo.org
  • USA - English


News provided by

The Buzz Agency

Jun 16, 2014, 17:35 ET

Share this article

Share toX

Share this article

Share toX


Palm Beach County, FL (PRWEB) June 16, 2014 -- Florida has become the 22nd state in the nation (23rd to legalize, including Washington, D.C.) to pass legislation supporting the use of marijuana for medicinal purposes. Governor Rick Scott signed Senate Bill 1030 (the "Charlotte's Web" bill) today, with overwhelming support of Florida citizens and the Florida legislature. The bill passed 111-7 in the House and 30-9 in the Senate.

This is definitely a major step in furthering medical marijuana usage in our state," said David Cohn, Editor-In-Chief of FloridaMarijuanaInfo.org

Post this

"This is definitely a major step in furthering medical marijuana usage in our state," said David Cohn, Editor-In-Chief of FloridaMarijuanaInfo.org. "But it's important our citizens clearly understand what this bill means to people suffering from debilitating diseases, and the pros and the cons associated with it."

OVERVIEW on FloridaMarijuanaInfo.org
FloridaMarijuanaInfo.org is an unbiased, non-partisan, informational hub launched in 2013 designed to give the public free access to incisive, authoritative, thought-provoking and instructional information about 'all things marijuana' in Florida. The organization takes no public stand for or against medical or recreational marijuana usage.

ABOUT SB 1030
In its most simple form, SB1030 decriminalizes a medical professionals' recommendation and patient's use of a particular strain of a low-THC cannibis for specific medicinal purposes. It means a doctor can 'order' the usage of a certain strain of cannabis for treatment of specific ailments as outlined in the bill. These ailments include cancer, Parkinson's disease, multiple sclerosis, other physical medical conditions that chronically produce symptoms of seizures or severe and persistent muscle spasms, and its original intended purpose - pediatric epilepsy (the strain named 'Charlotte's Web' after Charlotte Figi, a five-year old who experienced a reduction of seizures after taking the drug.)

The physicians must be appropriately licensed and patients must be Florida residents. The physician must add the patient to the newly formed "compassionate use registry."

It allows for five (5) companies to be licensed to cultivate, process and dispense the approved strain in an oil format. These companies would be based in four corners of the state, and one in the center of the state.
It does not allow a smokable form of marijuana; only the oil form is included in the legislation.

PROS
1. Florida is on the forefront of this issue, and it is setting a precedent for other Southern states, which traditionally may not support what is perceived as a 'blue state' issue. Florida has been bi-partisan in this initiative, and that is definitely a positive.
2. The bill opens the doors for doctors to recommend an effective treatment program for their patients that, according to a number of studies, can be cost effective; has fewer side effects; and strong healing possibilities.
3. The bill allows for our state universities with agricultural and medical programs to conduct research to develop new forms of treatment; a great opportunity for medical advancement to take place in Florida.

CONS
1. The Bill creates a monopoly in the hands of five businesses, severely limiting competition and free enterprise. More research and public inquisition needs to be done to determine exactly who these five companies are, what criteria is being used to select them, how they will be regulated, and to whom they report.
2. While the last minute expansion of the Bill allows for additional ailments to be covered, there are still hundreds of thousands of Floridians who will not be covered under the legislation, such as those with HIV/Aids, Alzheimer's, dementia, mental disabilities (Post-traumatic stress disorder) and others.
3. The bill only allocates $1 Million to oversee the entire "cannabis" program; leaving room for potential corruption and mismanagement.

"We are following this story intensely," said Cohn, "and we have outlined some items we believe the public should be aware of. As we get closer to the November 2 ballot initiative, we will be commenting on how the legalization of marijuana for medical use will impact the state of Florida; including Florida's economy, health-care system, the travel industry, etc."

The FloridaMarijuanaInfo.org mission to provide the most accurate and useful information about marijuana, with a specific focus on Florida. The group strongly encourages the public to interact with their online community through the forum, comments sections, and blog.

FloridaMarijuanaInfo.org believes that "knowledge is power." Our dedication to providing the most up-to-date information regarding the latest news, opinions, reports, legal updates and analysis, and cutting-edge scientific research to the Florida community is our only goal.

To learn more, visit http://www.FloridaMarijuanaInfo.org; facebook.com/FloridaMJInfo and on Twitter @FLMarijuanaInfo.

###

Julie Mullen, The Buzz Agency, http://www.thebuzzagency.net, +1 (855) 525-2899, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.